What Eli Lilly Was Telling You While It Rationed Its Own Launches

TL;DR

BMO reiterates Eli Lilly stock rating on incretin growth outlook Lilly Kept Saying It Could Not Build Fast Enough In early February 2025 the CEO said the capacity Lilly had already built was not enough to meet global demand, and that the company was still gating promotion and gating launches around the world. That is a company telling you its reported revenue understates what its products could sell. The build was landing.